Funds holding HYPERLIQUID STRATEGIES INC
14 funds declare a position · 3 ETFs and 11 other funds · 22.5M $· 4.3K € · US44916Y1064
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2,451,336 | 12.5M $ | 0.17 % | as of Mar 31, 2026 · Original filing |
| 2 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,385,074 | 7.1M $ | 0.01 % | as of Mar 31, 2026 · Original filing |
| 3 | iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 172,258 | 876.8K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 4 | Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 142,920 | 860.4K $ | 0.17 % | as of Apr 30, 2026 · Original filing |
| 5 | Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 78,272 | 471.2K $ | 0.00 % | as of Apr 30, 2026 · Original filing |
| 6 | Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 71,125 | 290.2K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 7 | BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 44,231 | 266.3K $ | 0.15 % | as of Apr 30, 2026 · Original filing |
| 8 | Onchain Economy ETF VanEck Funds | 24,000 | 122.2K $ | 0.23 % | as of Mar 31, 2026 · Original filing |
| 9 | PROFUND VP BIOTECHNOLOGY ProFunds | 13,646 | 69.5K $ | 0.17 % | as of Mar 31, 2026 · Original filing |
| 10 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 7,667 | 31.3K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 11 | Fidelity Total Market Index Fund Fidelity Concord Street Trust | 2,169 | 8.8K $ | as of Feb 28, 2026 · Original filing | |
| 12 | Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 1,729 | 7.1K $ | as of Feb 28, 2026 · Original filing | |
| 13 | State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 662 | 3.4K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 14 | CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 4.3K € | 0.31 % | as of Dec 31, 2025 · Original filing |
Institutional managers
85 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| D1 Capital Partners L.P. | 8,000,000 | 40.7M $ | as of Mar 31, 2026 |
| Paradigm Operations LP | 5,709,852 | 29.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,147,029 | 16M $ | as of Mar 31, 2026 |
| Galaxy Group Investments LLC | 4,260,476 | 15.2M $ | as of Dec 31, 2025 |
| Pantera Capital Partners LP | 2,712,928 | 13.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 2,077,514 | 10.6M $ | as of Mar 31, 2026 |
| OLP CAPITAL MANAGEMENT Ltd | 2,054,855 | 10.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,471,129 | 7.5M $ | as of Mar 31, 2026 |
| PEAK6 LLC | 1,399,134 | 7.1M $ | as of Mar 31, 2026 |
| Arrington Capital Management, LLC | 1,220,001 | 6.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,144,398 | 5.8M $ | as of Mar 31, 2026 |
| Galaxy Digital Inc. | 899,951 | 4.6M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 899,303 | 4.6M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 850,000 | 4.3M $ | as of Mar 31, 2026 |
| GM Advisory Group, LLC | 827,644 | 4.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 654,630 | 3.3M $ | as of Mar 31, 2026 |
| Militia Capital Management LLC | 652,902 | 3.3M $ | as of Mar 31, 2026 |
| MAPLELANE CAPITAL, LLC | 575,000 | 2.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 551,847 | 2.8M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 539,645 | 2.7M $ | as of Mar 31, 2026 |
| Saba Capital Management, L.P. | 471,964 | 2.4M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 366,758 | 1.9M $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 334,999 | 1.7M $ | as of Mar 31, 2026 |
| ARISTEIA CAPITAL, L.L.C. | 324,757 | 1.7M $ | as of Mar 31, 2026 |
| Kultura Capital Management LP | 305,300 | 1.6M $ | as of Mar 31, 2026 |